Neurologic Imaging

Which Imaging Study Is Best for Initial Staging of Sinonasal Cancer?

·
Which Imaging Study Is Best for Initial Staging of Sinonasal Cancer?

A 64-year-old patient presents to your clinic with several months of unilateral nasal obstruction and intermittent epistaxis. An otolaryngology (ENT) evaluation with nasal endoscopy revealed a mass in the right maxillary sinus, and a subsequent biopsy confirmed squamous cell carcinoma. The case is now scheduled for the multidisciplinary tumor board, but first, you need to order the right imaging to accurately stage the disease and guide treatment. The complex anatomy of the sinonasal region, with its proximity to the orbits, cranial nerves, and brain, makes this a high-stakes decision. According to the American College of Radiology (ACR) Appropriateness Criteria, `MRI orbits face neck without and with IV contrast` is rated Usually Appropriate as the primary study for this clinical scenario.

Who Fits This Clinical Scenario?

This guidance applies specifically to patients with a new, suspected, or biopsy-proven malignancy of the paranasal sinuses (maxillary, ethmoid, sphenoid, or frontal) or the nasal cavity who require initial staging. The primary goal is to define the full extent of the primary tumor, assess for regional lymph node involvement, and evaluate for distant metastatic disease before any treatment has been initiated. This workflow is critical for determining the tumor (T), node (N), and metastasis (M) stage, which dictates prognosis and therapy.

It is crucial to distinguish this scenario from similar but distinct clinical presentations that follow different imaging pathways:

  • Nasopharyngeal Carcinoma: Cancers arising in the nasopharynx have unique patterns of spread and a strong association with Epstein-Barr virus (EBV). This requires a dedicated staging protocol, which is covered in a separate ACR variant.
  • Oral Cavity or Oropharyngeal Cancers: Tumors of the tongue, floor of mouth, or tonsils have different local invasion patterns and lymphatic drainage pathways compared to sinonasal cancers.
  • Post-Therapy Surveillance: This article does not cover imaging for patients who have already completed treatment and are being monitored for recurrence. Surveillance imaging has its own set of recommendations.

What Diagnoses Are You Working Up in This Scenario?

While a cancer diagnosis is already suspected or confirmed, the purpose of staging imaging is to answer critical questions about the tumor’s extent. The “differential” in this context is less about the primary diagnosis and more about the presence and degree of local, regional, and distant spread, which profoundly impacts the treatment plan.

Perineural and Intracranial Spread: This is a primary concern in sinonasal cancers. The imaging must be sensitive enough to detect tumor tracking along branches of the trigeminal (V) and other cranial nerves. This finding upstages the tumor and often makes surgical resection more complex or even impossible. The study must also clearly delineate any extension through the skull base into the dura or brain parenchyma.

Orbital Invasion: The paranasal sinuses are intimately related to the orbits. The imaging study must precisely define any invasion into the orbital fat, extraocular muscles, or optic nerve. Even minor orbital involvement can necessitate an orbital exenteration, a decision with life-altering consequences for the patient.

Regional Nodal Metastasis: The presence of cancer in the cervical lymph nodes is one of the most important prognostic factors. Imaging must survey the entire neck to identify suspicious nodes (based on size, morphology, and presence of central necrosis) to guide whether a neck dissection or targeted radiation is required.

Bony Invasion: The extent of bone destruction of the sinus walls, hard palate, pterygoid plates, and skull base is a key component of T-staging. This information is vital for surgical planning to ensure negative margins can be achieved.

Why Is MRI of the Orbits, Face, and Neck the Recommended Staging Study?

For the initial staging of sinonasal cancer, the ACR panel designates `MRI orbits face neck without and with IV contrast` as Usually Appropriate. The rationale is grounded in MRI’s superior ability to characterize soft tissue and its specific advantages in this anatomically dense region.

The primary strength of MRI is its exceptional soft-tissue contrast resolution. This makes it the most sensitive modality for detecting subtle but critical findings like perineural spread, where tumor enhances along a cranial nerve, and dural enhancement, which signals intracranial extension. These are often occult on other imaging types. Furthermore, MRI excels at differentiating tumor from adjacent inflamed mucosa or trapped secretions within the sinuses, a common confounding factor. The use of intravenous contrast is essential, as it highlights the tumor and makes perineural and dural involvement conspicuous, particularly on fat-suppressed sequences.

While MRI is the top-rated study, other modalities are considered for specific, often complementary, roles:

  • CT neck with IV contrast: Also rated Usually Appropriate, CT is superior to MRI for delineating cortical bone destruction. For this reason, it is often performed in addition to MRI as part of preoperative planning to give surgeons a precise map of bony erosion. However, it is less sensitive for perineural, dural, and orbital soft-tissue invasion, making it less ideal as the sole primary staging study. It involves an adult radiation dose of 1-10 mSv.
  • FDG-PET/CT skull base to mid-thigh: This is also Usually Appropriate and is invaluable for detecting nodal and distant metastases. It assesses metabolic activity, which can identify cancerous deposits throughout the body that are not enlarged or visible on anatomic imaging alone. It is often used to complete the staging workup, especially for advanced-stage or high-grade tumors.
  • US neck: Rated May be appropriate, ultrasound is a useful adjunct for evaluating suspicious cervical lymph nodes and can guide fine-needle aspiration (FNA) for definitive cytological diagnosis. However, it cannot visualize the primary tumor within the sinonasal cavity and is therefore not a comprehensive staging tool.

The choice of MRI as the primary study leverages its non-ionizing radiation nature (0 mSv) while providing the most critical soft-tissue information needed to make foundational treatment decisions.

What’s the Next Step After the Initial Staging MRI?

The results of the staging MRI are a central data point for the multidisciplinary tumor board, which typically includes ENT surgery, radiation oncology, medical oncology, radiology, and pathology. The downstream workflow is dictated directly by the imaging findings.

If the MRI shows localized disease amenable to surgery: The patient will likely be scheduled for surgical resection. As noted, a complementary CT scan is often ordered to provide a detailed “bony map” for the surgeon. The MRI will also guide the extent of the surgery, such as determining the need for orbital exenteration or a combined craniofacial approach if skull base involvement is present.

If the MRI shows unresectable disease: Findings such as extensive intracranial extension, cavernous sinus invasion, or encasement of the internal carotid artery may render the tumor surgically unresectable. In these cases, the patient will typically be referred for definitive chemoradiation as the primary treatment modality.

If the MRI shows equivocal or suspicious lymph nodes: This is a key indication to proceed with `FDG-PET/CT skull base to mid-thigh`. A metabolically active node on PET/CT is highly suggestive of metastasis and will confirm the need to treat the neck with either surgery or radiation. PET/CT also serves as a whole-body screen for distant disease, which, if present, would dramatically alter the treatment intent from curative to palliative.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for sinonasal cancer requires careful attention to detail to avoid common errors. One major pitfall is ordering an MRI of the “brain” or “sinuses” instead of the comprehensive “orbits, face, and neck” protocol; this can result in an inadequate field of view that misses cervical lymph node metastases. Another error is failing to order the study with and without intravenous contrast, as non-contrast MRI is insufficient for evaluating perineural or dural spread. Finally, relying solely on CT can lead to under-staging by missing the soft-tissue and neural invasion that MRI detects best. If the imaging report is ambiguous about these key high-risk features, direct consultation with the interpreting neuroradiologist is essential to clarify the findings before finalizing a treatment plan.

Related ACR Topics and Tools

For a comprehensive overview of imaging recommendations across all head and neck cancer scenarios, from staging to post-therapy assessment, please refer to our parent topic hub article. For further exploration of specific imaging protocols or to compare radiation doses, the following GigHz resources are available.

Frequently Asked Questions

Why is MRI preferred over CT for initial staging of sinonasal cancer?

MRI is preferred because of its superior soft-tissue contrast, which is critical for evaluating key prognostic factors like perineural spread along cranial nerves, dural invasion (intracranial extension), and subtle orbital invasion. While CT is better for showing bone destruction and is often used as a complementary study for surgical planning, it can miss these subtle but critical soft-tissue findings, potentially leading to under-staging.

Is a PET/CT scan always necessary for staging nasal and paranasal sinus cancers?

Not always, but it is rated ‘Usually Appropriate’ by the ACR and is frequently used. Its primary roles are to detect regional lymph node metastases that may not be apparent on MRI/CT and to screen for distant metastatic disease. It is most critical for patients with advanced local disease (T3/T4), high-grade tumors, or suspicious findings on the initial MRI or CT.

What specific information should I include when ordering the MRI?

When ordering, specify ‘MRI orbits, face, and neck without and with IV contrast.’ It is also helpful to provide the clinical history, including the site of the tumor and the known histology (e.g., ‘biopsy-proven squamous cell carcinoma of the right maxillary sinus’). This ensures the radiologist uses the correct protocol with thin slices and fat-suppressed sequences optimized for detecting perineural and intracranial spread.

If the patient has a contraindication to MRI (e.g., a non-compatible pacemaker), what is the best alternative?

If MRI is contraindicated, the best alternative is a high-resolution ‘CT neck with IV contrast.’ This will provide excellent detail of bony erosion and can assess for nodal disease. Its limitation is the reduced sensitivity for perineural and dural spread. In this situation, an ‘FDG-PET/CT skull base to mid-thigh’ becomes even more important to complete the staging by assessing for nodal and distant disease.

Does this imaging guidance apply to benign tumors of the sinuses, like an inverted papilloma?

While the imaging modalities are similar, the clinical question is different. For a suspected benign but locally aggressive tumor like an inverted papilloma, the primary goal is to define the extent for complete surgical resection. Both CT (for bone) and MRI (for soft tissue and to look for foci of malignant transformation) are often used. This specific ACR guideline is optimized for staging known or highly suspected malignancy, where questions of nodal and distant metastasis are paramount.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026